Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma

被引:27
|
作者
Ohmura, Shunya [1 ,2 ,3 ,4 ]
Marchetto, Aruna [4 ]
Orth, Martin F. [4 ]
Li, Jing [1 ,2 ,3 ]
Jabar, Susanne [5 ,6 ]
Ranft, Andreas [5 ,6 ]
Vinca, Endrit [1 ,2 ,3 ]
Ceranski, Katharina [1 ,2 ,3 ]
Carreno-Gonzalez, Martha J. [1 ,2 ,3 ]
Romero-Perez, Laura [1 ,2 ,3 ,4 ]
Wehweck, Fabienne S. [4 ]
Musa, Julian [1 ,2 ,3 ,4 ,7 ]
Bestvater, Felix [8 ]
Knott, Maximilian M. L. [4 ]
Hoelting, Tilman L. B. [4 ]
Hartmann, Wolfgang [9 ]
Dirksen, Uta [5 ,6 ]
Kirchner, Thomas [10 ,11 ]
Cidre-Aranaz, Florencia [1 ,2 ,3 ,4 ]
Grunewald, Thomas G. P. [1 ,2 ,3 ,4 ,12 ]
机构
[1] Hopp Childrens Canc Ctr Heidelberg KiTZ, Heidelberg, Germany
[2] German Canc Res Ctr, Div Translat Pediat Sarcoma Res B410, Neuenheimer Feld 280, D-69210 Heidelberg, Germany
[3] Hopp Childrens Canc Ctr KiTZ, Neuenheimer Feld 280, D-69210 Heidelberg, Germany
[4] Ludwig Maximilians Univ Munchen, Inst Pathol, Fac Med, Max Eder Res Grp Pediat Sarcoma Biol, Munich, Germany
[5] Univ Hosp Essen, West German Canc Ctr, Pediat 3, Essen, Germany
[6] German Canc Consortium DKTK, Partner Site Essen, Essen, Germany
[7] Heidelberg Univ Hosp, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany
[8] German Canc Consortium DKTK, Light Microscopy Facil, German Canc Res Ctr DKFZ, Heidelberg, Germany
[9] Univ Hosp Munster, Gerhard Domagk Inst Pathol, Div Translat Pathol, Munster, Germany
[10] Ludwig Maximilians Univ Munchen, Inst Pathol, Fac Med, Munich, Germany
[11] German Canc Consortium DKTK, Partner Site Munich, Munich, Germany
[12] Heidelberg Univ Hosp, Inst Pathol, Heidelberg, Germany
关键词
Ewing sarcoma; RRM2; Targeted therapy; Prognostic biomarker; Paediatric oncology; Triapine; Chemoresistance; RIBONUCLEOTIDE REDUCTASE INHIBITOR; GTI-2040 PLUS DOCETAXEL; 3-AMINOPYRIDINE-2-CARBOXALDEHYDE THIOSEMICARBAZONE; PHASE-I/II; MANAGEMENT; RECURRENCE;
D O I
10.1186/s12943-021-01393-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Bioinformatics analysis revealing prognostic significance of RRM2 gene in breast cancer
    Chen, Wei-xian
    Yang, Liang-gen
    Xu, Ling-yun
    Cheng, Lin
    Qian, Qi
    Sun, Li
    Zhu, Yu-lan
    BIOSCIENCE REPORTS, 2019, 39
  • [22] V-ATPase is a candidate therapeutic target for Ewing sarcoma
    Avnet, Sofia
    Di Pompo, Gemma
    Lemma, Silvia
    Salerno, Manuela
    Perut, Francesca
    Bonuccelli, Gloria
    Granchi, Donatella
    Zini, Nicoletta
    Baldini, Nicola
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2013, 1832 (08): : 1105 - 1116
  • [23] RRM2 and mutant p53 as therapeutic targets in TNBC.
    Sultana, Nahid
    Wilson, Elizabeth A.
    Elford, Howard L.
    Faridi, Jesika S.
    CANCER RESEARCH, 2021, 81 (13)
  • [24] Prognostic and therapeutic relevance of HER2 expression in osteosarcoma and Ewing's sarcoma
    Scotlandi, K
    Manara, MC
    Hattinger, CM
    Benini, S
    Perdichizzi, S
    Pasello, M
    Bacci, G
    Zanella, L
    Bertoni, F
    Picci, P
    Serra, M
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (09) : 1349 - 1361
  • [25] Preclinical validation of EZH2 as a therapeutic target in pediatric Ewing's sarcoma
    Pandya, Pankita H.
    Bailey, Barbara
    Elmi, Adily E.
    Bates, Heather R.
    Hemenway, Courtney N.
    Sinn, Anthony L.
    Bijangi-Vishehsaraei, Khadijeh
    Saadatzadeh, M. Reza
    Shannon, Harlan E.
    Ding, Jixin
    Marshall, Mark S.
    Ferguson, Michael J.
    Cheng, Lijun
    Li, Lang
    Murray, Mary E.
    Renbarger, Jamie L.
    Pollok, Karen E.
    CANCER RESEARCH, 2018, 78 (13)
  • [26] Inhibition of the ATR-CHK1 Pathway in Ewing Sarcoma Cells Causes DNA Damage and Apoptosis via the CDK2-Mediated Degradation of RRM2
    Koppenhafer, Stacia L.
    Goss, Kelli L.
    Terry, William W.
    Gordon, David J.
    MOLECULAR CANCER RESEARCH, 2020, 18 (01) : 91 - 104
  • [27] sCLU as prognostic biomarker and therapeutic target in osteosarcoma
    Ma, Jinfeng
    Gao, Weiliang
    Gao, Jisheng
    BIOENGINEERED, 2019, 10 (01) : 229 - 239
  • [28] RRM2 expression in different molecular subtypes of breast cancer and its prognostic significance
    Manar Ahmed Abdel-Rahman
    Mena Mahfouz
    Hany Onsy Habashy
    Diagnostic Pathology, 17
  • [29] RRM2 expression in different molecular subtypes of breast cancer and its prognostic significance
    Abdel-Rahman, Manar Ahmed
    Mahfouz, Mena
    Habashy, Hany Onsy
    DIAGNOSTIC PATHOLOGY, 2022, 17 (01)
  • [30] Prognostic and therapeutic relevance of the IGF pathway in Ewing's sarcoma patients
    van de Luijtgaarden, A. C. M.
    Versleijen-Jonkers, Y. M. H.
    Roeffen, M. H. S.
    Schreuder, H. W. B.
    Flucke, U. E.
    van der Graaf, W. T. A.
    TARGETED ONCOLOGY, 2013, 8 (04) : 253 - 260